A Phase III Clinical Study of Minodronate Tablets in Postmenopausal Women With Osteoporosis
Status:
Not yet recruiting
Trial end date:
2024-05-31
Target enrollment:
Participant gender:
Summary
In the randomized, active-controlled, double-blinded, multicenter study, the efficacy and
safety of monthly oral minodronate were examined and compared to that of weekly oral
alendronate.